Long Beach, CA12 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Long Beach, CA

Find 12 actively recruiting myalgic encephalomyelitis clinical trials in Long Beach, CA. Connect with local research sites and explore new treatment options.

12
Active Trials
10
Sponsors
41,065
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Long Beach

About Myalgic Encephalomyelitis Clinical Trials in Long Beach

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 12 myalgic encephalomyelitis clinical trials recruiting participants in Long Beach, CA. These studies are seeking a combined 41,065 participants. Research is being sponsored by Duke University, Hoffmann-La Roche, The University of Texas Health Science Center, Houston and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Long Beach — FAQ

Are there myalgic encephalomyelitis clinical trials in Long Beach?

Yes, there are 12 myalgic encephalomyelitis clinical trials currently recruiting in Long Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Long Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.

Are clinical trials in Long Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 12 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 19, 2026 from ClinicalTrials.gov